Loading…
Dr. Reddy's Laboratories (DRREDDY)₹1,385+1.09%Pharmaceuticals
At the end of the Sep 2026 quarter, Dr. Reddy's Laboratories' shareholders were: promoters 26.68%, FIIs 20.34%, DIIs 31.85%, public 20.94%, others 0.19%. Promoter holding is unchanged on the quarter. FII holding is down 4.39 percentage points from 24.73% a year earlier. 0.00% of promoter shares were pledged. It had 4,76,774 shareholders.
As of · Company filings (shareholding pattern)
| Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 26.70% | 26.70% | 26.70% | 26.69% | 26.69% | 26.69% | 26.69% | 26.69% | 26.69% | 26.68% | 26.68% | 26.68% |
| FIIs | 28.66% | 29.17% | 27.72% | 27.57% | 26.89% | 25.79% | 25.37% | 24.73% | 22.38% | 21.18% | 20.71% | 20.34% |
| DIIs | 18.63% | 18.29% | 20.70% | 21.46% | 22.87% | 25.61% | 26.71% | 27.97% | 30.42% | 30.70% | 31.73% | 31.85% |
| Public | 25.83% | 25.67% | 24.71% | 24.12% | 23.39% | 21.62% | 20.97% | 20.36% | 20.26% | 21.20% | 20.68% | 20.94% |
| Others | 0.18% | 0.17% | 0.17% | 0.16% | 0.16% | 0.29% | 0.26% | 0.25% | 0.25% | 0.24% | 0.20% | 0.19% |
| Promoter shares pledged | — | — | — | — | — | — | — | — | — | — | — | 0.00% |
| Number of shareholders | 2,57,844 | 2,55,550 | 2,67,746 | 3,10,464 | 4,03,748 | 4,59,695 | 4,52,017 | 4,49,304 | 4,55,332 | 4,49,753 | 4,46,173 | 4,76,774 |
| Holder | Category | Sep 2026 | Change (pp) |
|---|---|---|---|
| Life Insurance Corporation Of India P & Gs Fund | DII | 12.09% | −0.02 |
| GVP Family Trust | Promoter | 11.52% | 0.00 |
| J P Morgan Chase Bank NA | Public | 11.09% | −0.31 |
| VSD Family Trust | Promoter | 9.11% | 0.00 |
| Isif Equity Ex-Top 100 Long-Short Fund | DII | 5.75% | New |
| Kallam Satish Reddy Huf | Promoter | 3.32% | 0.00 |
| Nps Trust-A/C Sbi Pension Fund Scheme Tax Saver-Tier 2 | DII | 2.92% | −0.22 |
| Nippon Life India Trustee Ltd-A/C-Nippon India Nifty 50 Value 20 Index Fund | DII | 1.57% | −0.30 |
| Gunupati Venkateswara Prasad Huf | Promoter | 1.53% | 0.00 |
| Parag Parikh Flexi Cap Fund | DII | 1.47% | −0.30 |
| Sbi Nifty Index Fund | DII | 1.20% | −0.22 |
| Satish Reddy Kallam | Promoter | 1.20% | 0.00 |
| Anuradha Gunupati | Promoter | 0.01% | 0.00 |
| Icici Prudential Value Discovery Fund | DII | Exited | — |
| Government Pension Fund Global | FII | Exited | — |
| APS Trust | Promoter | 0.00% | 0.00 |
| Gunupati Venkateswara Prasad | Promoter | 0.00% | 0.00 |
Promoters held 26.68% of Dr. Reddy's Laboratories at the end of the Sep 2026 quarter, down 0.01 percentage points from 26.69% a year earlier.
In the Sep 2026 quarter, foreign institutional investors (FIIs) held 20.34% (down 0.37 percentage points from 20.71% a quarter earlier) and domestic institutions (DIIs) held 31.85% (up 0.12 percentage points from 31.73% a quarter earlier).
No. The Sep 2026 filing shows no pledged promoter shares.
Dr. Reddy's Laboratories had 4,76,774 shareholders at the end of the Sep 2026 quarter, against 4,49,304 a year earlier.
Life Insurance Corporation Of India P & Gs Fund (DII) held 12.09% at the end of the Sep 2026 quarter, the largest named holding outside the promoter group.